Supportive Care News & Features
Cancer appears to be overtaking cardiovascular disease (CVD) as the leading cause of mortality in many European countries.
Quantifications of quality of life or patient-reported outcomes will offer more information for treatment-planning discussions.
Humans can tolerate tumors in large or paired organs more easily than in small, critical organs, and the larger organs may therefore have evolved fewer mechanisms to defend against cancerous cells.
Infrared laser moxibustion may be safe and efficacious for improving cancer-related fatigue.
From 1997 to 2014 the estimated rate of annual increase in obesity prevalence was higher for adults with a history of cancer.
More in Supportive Care
ANAHEIM, CALIFORNIA—A multidisciplinary approach that also heavily incorporates input from patients and their families helped alleviate concerns about inappropriate use of palliative sedation and improved patient-centered care, a speaker said at the Oncology Nursing Society (ONS) 39th Annual Congress.
Inadequate pain management, baseline pain severity linked to pain deterioration
Duloxetine is effective in reducing pain in patients with painful chemotherapy-induced peripheral neuropathy, especially in those receiving drug as initial treatment.
A Canadian study has identified factors associated with opioid prescriptions for severe pain in the elderly: younger age, male sex, comorbid illness, type of cancer, and assessment at home, results of a study in the Journal of Clinical Oncology published online February 27 has found.
Intrathecal Therapy Cost-Effective for Patients with Cancer Pain Who Have a Favorable Life-Expectancy
In selected patients with cancer pain on high-cost conventional regimens, intrathecal therapy may become cost-effective as early as seven months following implant, and greater duration of therapy is associated with reduced costs.
The introduction of palliative care shortly after a patient is diagnosed with cancer is associated with improved quality of life.
Continuous deep sedation (CDS) should be considered a viable option for patients with advanced cancer being cared for in a palliative setting.
Olanzapine, an antipsychotic, significantly improves nausea and vomiting in chemotherapy patients, according to results of a phase 3, randomized trial.
The median opioid rotation ratio (ORR) from the oral morphine equivalent daily dose (MEDD) to transdermal fentanyl in milligrams per day was 0.01.
Patients with advanced cancer and delirium at an acute palliative care unit (APCU) had a poorer survival rate.
Pacritinib, an investigational oral multikinase inhibitor, improves spleen volume reduction among high-risk patients with advanced myelofibrosis.
Patients who slept poorly exhibited greater symptom burden and overall mood disturbance.
A patient's expectations may influence his or her adherence to medication regimens, quality of life, and reported side effects.
Risk factors for depression symptoms signify the need for enhanced surveillance among some subgroups of patients with lung cancer.
Diabetes is associated with increased mortality from cardiovascular disease, cancer, and noncardiovascular noncancer causes.
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- PAP Series: Patient Assistance Programs "Culprits" of Rising Drug Prices
- Sleep Cycle May Be a Causal Factor of Chronic Lymphocytic Leukemia
- A Call for a New Collaboration to Cure Melanoma
- Scan-associated Distress May Be Persistent for Patients With NSCLC
- Polycystic Kidney Disease Correlated With Risk of Cancer
- Head and Neck Cancers Treatment Regimens
- TRUS-biopsy Poorly Detects Prostate Cancer
- Model Predicts That Healthful Lifestyle Benefits Women at Risk of Breast Cancer
- Cobimetinib Plus Atezolizumab Active in Colorectal Cancer
- Serum Carbonic Anhydrase IV Predictive of Bevacizumab Efficacy in Breast Cancer
- CTA Treatment Regimen Chart for Head and Neck Cancer Updated
- Head and Neck Cancers Treatment Regimens
- Pacritinib Improves Spleen Volume Recovery in Advanced Myelofibrosis
- Alternative Metrics of Response Correlate With OS in FIRE-3 Trial
- Sentinel Lymph Node Biopsy Recommended for Patients With Sarcoma